As expected, AKT phosphorylation was elevated by PTEN knockdown in PTEN‐positive 22Rv1 prostate cancer cells, but PTEN loss‐enhanced AKT phosphorylation was mitigated by HDAC3 co‐knockdown (Fig 6A). This evidence concerns the gene PTEN and prostate carcinoma.